Iskandar et al. BMC Public Health 2010, 10:472 http://www.biomedcentral.com/1471-2458/10/472 11. Heckathorn DD, Semaan S, Broadhead RS, Hughes JJ: Extensions of respondent-driven sampling: a new approach to the study of injection drug users aged 18-25. AIDS Behav 2002, 6(1):55-67. 12. Salganik MJ, Heckathorn DD: Sampling and Estimation in Hidden Populations Using Respondent Driven Sampling. Sociol Method 2004, 34:193-240. 13. Alisjahbana B, Susanto H, Roesli R, Yusuf H, Hinduan Z, Mose JC, Surahman E, Ven Avd: Prevention, Control, and Treatment of HIV-AIDS among Injecting Drug User in Bandung, Indonesia. Acta Med Indones 2009, 41(Supplement 1):65-69. 14. Addiction Severity Index: Manual and Question by Question Guide. [http://www.tresearch.org/resources/manuals/ASIQbyQGuide.pdf]. 15. McLellan AT, Cacciola JS, Alterman AI, Rikoon SH, Carise D: The Addiction Severity Index at 25: origins, contributions and transitions. Am J Addict 2006, 15(2):113-124. 16. WHO Collaborative Study on Substitution Therapy of Opioid Dependence and HIV/AIDS: General Protocol. [http://www.who.int/ substance_abuse/research_tools/translation/en/print.html]. 17. Fry CL, Lintzeris N: Psychometric properties of the Blood-borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ). Addiction 2003, 98(2):171-178. 18. Tucker T, Fry CL, Lintzeris N, Baldwin S, Ritter A, Donath S, Whelan G: Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users. Addiction 2004, 99(9):1157-1166. 19. Wisaksana R, Indrati AK, Fibriani A, Rogayah E, Sudjana P, Djajakusumah TS, Sumantri R, Alisjahbana B, van der Ven A, van Crevel R: Response to first- line antiretroviral treatment among human immunodeficiency virus- infected patients with and without a history of injecting drug use in Indonesia. Addiction (Abingdon, England) 2010. 20. Afriandi I, Aditama TY, Mustikawati D, Oktavia M, Alisjahbana B, Riono P: HIV and Injecting Drug Use in Indonesia: Epidemiology and National Response. Acta Med Indones 2009, 41(Supplement 1):75-78. 21. MoH, NAC, USAID, ASA, FHI: HIV/STI Integrated Biological Behavioral Surveillance (IBBS) among Most-at-Risk Group (MARG) in Indonesia. Ministry of Health, National AIDS Committee, Family Health International 2007. 22. Des Jarlais DC: Preventing HIV transmission among injecting drug users (IDUs) and from IDUs to noninjecting sexual partners in Sichuan, China. Sex Transm Dis 2007, 34(8):583-585. 23. Gossop M, Marsden J, Stewart D, Kidd T: Reduction or cessation of injecting risk behaviours? Treatment outcomes at 1-year follow-up. Addict Behav 2003, 28(4):785-793. 24. Lawrinson P, Ali R, Buavirat A, Chiamwongpaet S, Dvoryak S, Habrat B, Jie S, Mardiati R, Mokri A, Moskalewicz J, et al: Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction 2008, 103(9):1484-1492. 25. Roux P, Villes V, Blanche J, Bry D, Spire B, Feroni I, Carrieri MP: Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management. Drug Alcohol Depend 2008, 97(1- 2):105-113. 26. Arasteh K, Des Jarlais DC, Perlis TE: Alcohol and HIV sexual risk behaviors among injection drug users. Drug Alcohol Depend 2008, 95(1-2):54-61. 27. Rawson RA, Gonzales R, Pearce V, Ang A, Marinelli-Casey P, Brummer J: Methamphetamine dependence and human immunodeficiency virus risk behavior. J Subst Abuse Treat 2008, 35(3):279-284. 28. Neaigus A, Gyarmathy VA, Miller M, Frajzyngier V, Zhao M, Friedman SR, Des Jarlais DC: Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug Alcohol Depend 2007, 89(2-3):234-243. 29. Platt L, Wall M, Rhodes T, Judd A, Hickman M, Johnston LG, Renton A, Bobrova N, Sarang A: Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia. J Urban Health 2006, 83(6 Suppl):i39-53. 30. Trotter RT II, Bowen AM, Potter JM Jr: Network models for HIV outreach and prevention programs for drug users. NIDA Res Monogr 1995, 151:144-180. 31. Wood E, Kerr T, Marshall BD, Li K, Zhang R, Hogg RS, Harrigan PR, Montaner JS: Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ 2009, 338:b1649. Page 7 of 7 Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2458/10/472/prepub doi:10.1186/1471-2458-10-472 Cite this article as: Iskandar et al.: High risk behavior for HIV transmission among former injecting drug users:a survey from Indonesia. BMC Public Health 2010 10:472. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit